-
Rilonacept (Arcalyst) Helps Prevent Gout Flares
The interleukin-1 (IL-1) inhibitor rilonacept (Arcalyst) reduced gout flares associated with initiation of urate-lowering therapy in a phase II trial reported last month.
Reuters Health Information, February 3, 2012
-
Intense Chemo in Early Unfavorable Hodgkin's Disease
A trial of aggressive chemotherapy in early unfavorable Hodgkin's disease has shown improvement in two intermediate endpoints, freedom from treatment failure and progression-free survival.
Reuters Health Information, February 3, 2012
-
'Symbiotic' Dietary Supplements Ease Constipation in Women
"Symbiotic" dietary supplements can improve chronic constipation in women, a new study has found.
Reuters Health Information, February 3, 2012
-
H1N1 Pandemic Flu Vaccine May Protect Kids Across Two Seasons
H1N1 antibody levels remain high in children a year after immunization with a monovalent adjuvanted pandemic swine influenza vaccine, a UK team reports.
Reuters Health Information, February 3, 2012
-
Laparoscopic Uterine Cancer Staging: Slightly More Recurrences
Reuters Health Information, February 3, 2012
-
Current Protease Inhibitor Use Not Linked to Sudden Death
Reuters Health Information, February 3, 2012
-
Photos on School Lunch Trays Boost Veggie Intake
Heartwire, February 3, 2012
-
STS
Power-Transmission Technology Could Radically Change LVAD
Heartwire, February 3, 2012
-
CMS Draft of Proposed Coverage for TAVI
Heartwire, February 3, 2012
-
Heart Failure Linked to Loss of Brain Gray Matter
Heartwire, February 3, 2012
-
Lyme Disease Ticks Endemic in Northeast, Northern Midwest
Medscape Medical News, February 3, 2012
-
Guidelines Lead Femtosecond Laser Users to Billing Safe Harbors
Medscape Medical News, February 3, 2012